Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Integrated Diagnostics Holdings plc (8I8.F)

0.2680
+0.0020
+(0.75%)
As of 9:07:01 AM GMT+2. Market Open.
Loading Chart for 8I8.F
  • Previous Close 0.2660
  • Open 0.2640
  • Bid 0.2680 x --
  • Ask 0.3420 x --
  • Day's Range 0.2640 - 0.2680
  • 52 Week Range 0.2240 - 0.4560
  • Volume 1,825
  • Avg. Volume 30
  • Market Cap (intraday) 185.361M
  • Beta (5Y Monthly) 0.26
  • PE Ratio (TTM) 8.93
  • EPS (TTM) 0.0300
  • Earnings Date Apr 17, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jun 16, 2022
  • 1y Target Est --

Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalography, electroencephalogram, and electrocardiogram, as well as operates cath lab facilities. It operates in Egypt, Sudan, Nigeria, and the Kingdom of Saudi Arabia. The company was founded in 1979 and is based in Saint Helier, Jersey.

www.idhcorp.com

6,309

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 8I8.F

View More

Performance Overview: 8I8.F

Trailing total returns as of 5/8/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

8I8.F
29.10%
FTSE 100 (^FTSE)
5.02%

1-Year Return

8I8.F
4.69%
FTSE 100 (^FTSE)
2.74%

3-Year Return

8I8.F
69.54%
FTSE 100 (^FTSE)
16.18%

5-Year Return

8I8.F
69.09%
FTSE 100 (^FTSE)
44.60%

Compare To: 8I8.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 8I8.F

View More

Valuation Measures

Annual
As of 5/7/2025
  • Market Cap

    183.50M

  • Enterprise Value

    178.63M

  • Trailing P/E

    8.40

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.59

  • Price/Book (mrq)

    3.28

  • Enterprise Value/Revenue

    1.80

  • Enterprise Value/EBITDA

    4.91

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    18.84%

  • Return on Assets (ttm)

    11.79%

  • Return on Equity (ttm)

    30.56%

  • Revenue (ttm)

    5.72B

  • Net Income Avi to Common (ttm)

    1.08B

  • Diluted EPS (ttm)

    0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.75B

  • Total Debt/Equity (mrq)

    42.07%

  • Levered Free Cash Flow (ttm)

    1.33B

Research Analysis: 8I8.F

View More

Company Insights: 8I8.F

Research Reports: 8I8.F

View More